Ashton F E, Ryan J A, Diena B B, Frasch C E
J Med Microbiol. 1983 Nov;16(4):443-57. doi: 10.1099/00222615-16-4-443.
The ability of serotype 2 outer membrane protein (SP-2) of Neisseria meningitidis strain M986 serogroup B, serotype 2a (B, 2a) to stimulate antibody formation in hens and to confer protection against meningococcal challenge to embryos from immunised hens was investigated. Hens, housed with roosters, were immunised with 100 micrograms of SP-2 once a week for 5 weeks to maintain consistent levels of serum antibody during the study. Antibodies in sera of hens, yolks and plasma of 13-day-old embryos reacted in enzyme-linked immunosorbent assays and immunodiffusion with outer membrane vesicles (OMV) from serotypes 2a, 2b and 2c and most of the other prototype group B strains of N. meningitidis. Cross-reactivity of hen sera with most OMV appeared after only one injection of SP-2. Embryos from immunised hens were protected against challenge with up to 10,000 LD50 doses of either the homologous strain M986 (B, 2a) or strain M1011 (B, 2a). Protection was also evident against strains 614 (W135, 2a), S5896 (Y, 2c) and 2241 (C, 2a), but not against strain 78704 (C, 2a) despite strong cross-reactivity of antibody with OMV of this strain. Embryos were only partially protected against strain 78069 (B, 2b) and were fully susceptible to strain 2996 (B, 2b). Some protection was also obtained against meningococcal strains M1080 (B, 1), M982 (B,9), S3032 (B, 12), 79001 (B, 12), 79694 (B, 15-related) but not strain 77252 (B, nontypable). These results suggest that proteins extracted from both serotype 2a and 2b meningococci would provide the broadest protection against infection with group B, serotype 2 meningococci and that antibody, presumably directed against common peptides in the major outer membrane proteins, can prevent infection by some other disease-associated serotypes of N. meningitidis.
对B群、2a血清型脑膜炎奈瑟菌菌株M986的2型外膜蛋白(SP - 2)刺激母鸡产生抗体以及使免疫母鸡的胚胎抵御脑膜炎球菌攻击的能力进行了研究。将母鸡与公鸡一起饲养,每周用100微克SP - 2免疫一次,共免疫5周,以便在研究期间维持血清抗体水平一致。在酶联免疫吸附测定和免疫扩散试验中,母鸡血清、13日龄胚胎的蛋黄和血浆中的抗体与2a、2b和2c血清型以及大多数其他B群脑膜炎奈瑟菌原型菌株的外膜囊泡(OMV)发生反应。仅注射一次SP - 2后,母鸡血清与大多数OMV就出现了交叉反应。免疫母鸡的胚胎能抵御高达10,000个半数致死剂量的同源菌株M986(B,2a)或菌株M1011(B,2a)的攻击。对菌株614(W135,2a)、S5896(Y,2c)和2241(C,2a)也有明显的保护作用,但尽管抗体与该菌株的OMV有很强的交叉反应,对菌株78704(C,2a)却没有保护作用。胚胎对菌株78069(B,2b)仅有部分保护作用,对菌株2996(B,2b)则完全易感。对脑膜炎球菌菌株M1080(B,1)、M982(B,9)、S3032(B,12)、79001(B,12)、79694(B,15相关)也有一定保护作用,但对菌株77252(B,不可分型)没有保护作用。这些结果表明,从2a和2b血清型脑膜炎球菌中提取的蛋白对B群、2型脑膜炎球菌感染能提供最广泛的保护,并且推测针对主要外膜蛋白中共同肽段的抗体可以预防其他一些与疾病相关的脑膜炎奈瑟菌血清型的感染。